Overview
Evidence-based recommendations on artificial intelligence-derived software to help clinical decision making in stroke.
Last reviewed: 2 May 2024
This guidance was updated to include Viz in recommendation 1.1, because it now has a high enough class of CE mark to be included in the recommendations.
This guidance replaces NICE medtech innovation briefing 262 on RapidAI for analysing CT/MRI brain scans in people with suspected acute stroke.
Diagnostics guidance 57 has been migrated to HealthTech guidance 708.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.
Implementation
NICE has developed tools and resources, in association with relevant stakeholders, to help organisations put this guidance into practice, including an evidence generation plan. The evidence generation plan gives further information on the prioritised evidence gaps and outcomes, ongoing studies and potential real-world data sources. It includes how the evidence gaps could be resolved through real-world evidence studies.